Samsung Group said its near-replica of Johnson & Johnson’s blockbuster arthritis drug Remicade has been accepted for review by the U.S. Food and Drug Administration.
Baca Berita Asal
Bagikan Berita Ini
Monday, May 23, 2016
Tech
Samsung Targets U.S. Drug Market With Remicade Knockoff
Samsung Targets U.S. Drug Market With Remicade Knockoff
Samsung Group said its near-replica of Johnson & Johnson’s blockbuster arthritis drug Remicade has been accepted for review by the U.S. Food and Drug Administration.
Baca Berita Asal
Bagikan Berita Ini
Samsung Group said its near-replica of Johnson & Johnson’s blockbuster arthritis drug Remicade has been accepted for review by the U.S. Food and Drug Administration.
Baca Berita Asal
Bagikan Berita Ini
0 Response to "Samsung Targets U.S. Drug Market With Remicade Knockoff"
Post a Comment